These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 37290246)

  • 1. The association of urbanicity and travel time with lung cancer screening utilization.
    Melikam ES; Simmons V; Masoomkhah E; Franco R; Cartmell KB; Mayo R; Gimbel R; Okon M; Zhang L
    Cancer Epidemiol; 2023 Aug; 85():102396. PubMed ID: 37290246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung Cancer Screening Eligibility and Utilization Among Transgender Patients: An Analysis of the 2017-2018 United States Behavioral Risk Factor Surveillance System Survey.
    Stowell JT; Parikh Y; Tilson K; Narayan AK
    Nicotine Tob Res; 2020 Dec; 22(12):2164-2169. PubMed ID: 32623455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017-2019.
    Advani S; Zhang D; Tammemagi M; Akinyemiju T; Gould MK; Silvestri GA; Braithwaite D
    Ann Am Thorac Soc; 2021 Nov; 18(11):1886-1893. PubMed ID: 33939595
    [No Abstract]   [Full Text] [Related]  

  • 4. Lung Cancer Screening in Individuals With and Without Lung-Related Comorbidities.
    Metwally EM; Rivera MP; Durham DD; Lane L; Perera P; Lamb D; Henderson LM
    JAMA Netw Open; 2022 Sep; 5(9):e2230146. PubMed ID: 36066893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Washington State's Low Uptake of Lung Cancer Screening in Two Steps: A Geospatial Analysis of Patient Travel Time and Health Care Availability of Imaging Sites.
    Welch AC; Gorden JA; Mooney SJ; Wilshire CL; Zeliadt SB
    Chest; 2024 Sep; 166(3):622-631. PubMed ID: 38815622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Influencing the False Positive Rate in CT Lung Cancer Screening.
    Hammer MM; Byrne SC; Kong CY
    Acad Radiol; 2022 Feb; 29 Suppl 2(Suppl 2):S18-S22. PubMed ID: 32893112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population.
    Tailor TD; Tong BC; Gao J; Henderson LM; Choudhury KR; Rubin GD
    Chest; 2020 Nov; 158(5):2200-2210. PubMed ID: 32562612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation.
    Japuntich SJ; Krieger NH; Salvas AL; Carey MP
    J Natl Med Assoc; 2018 Oct; 110(5):424-427. PubMed ID: 30129479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung Cancer Screening: Characteristics of Nonparticipants and Potential Screening Barriers.
    Raju S; Khawaja A; Han X; Wang X; Mazzone PJ
    Clin Lung Cancer; 2020 Sep; 21(5):e329-e336. PubMed ID: 32371161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions and Utilization of Lung Cancer Screening Among Smokers Enrolled in a Tobacco Cessation Program.
    Raz DJ; Wu G; Nelson RA; Sun V; Wu S; Alem A; Haupt EC; Ismail MH; Gould MK
    Clin Lung Cancer; 2019 Jan; 20(1):e115-e122. PubMed ID: 30585165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial Differences in Lung Cancer Screening Beliefs and Screening Adherence.
    Barta JA; Shusted CS; Ruane B; Pimpinelli M; McIntire RK; Zeigler-Johnson C; Myers RE; Evans NR; Kane GC; Juon HS
    Clin Lung Cancer; 2021 Nov; 22(6):570-578. PubMed ID: 34257020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to Lung Cancer Screening in the Veterans Health Administration: Does Geographic Distribution Match Need in the Population?
    Boudreau JH; Miller DR; Qian S; Nunez ER; Caverly TJ; Wiener RS
    Chest; 2021 Jul; 160(1):358-367. PubMed ID: 33617804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions and Utilization of Lung Cancer Screening Among Primary Care Physicians.
    Raz DJ; Wu GX; Consunji M; Nelson R; Sun C; Erhunmwunsee L; Ferrell B; Sun V; Kim JY
    J Thorac Oncol; 2016 Nov; 11(11):1856-1862. PubMed ID: 27346412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
    Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
    Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared Decision-Making for Lung Cancer Screening: How Well Are We "Sharing"?
    Nishi SPE; Lowenstein LM; Mendoza TR; Lopez Olivo MA; Crocker LC; Sepucha K; Niu J; Volk RJ
    Chest; 2021 Jul; 160(1):330-340. PubMed ID: 33556362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
    Carroll NM; Burnett-Hartman AN; Joyce CA; Kinnard W; Harker EJ; Hall V; Steiner JS; Blum-Barnett E; Ritzwoller DP
    J Gen Intern Med; 2020 Apr; 35(4):1143-1152. PubMed ID: 31974902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and Facilitators to Lung Cancer Screening: A Physician Survey.
    Lowenstein M; Karliner L; Livaudais-Toman J; Gregorich S; Velazquez AI; Vijayaraghavan M; Walsh JME; Kaplan CP
    Am J Health Promot; 2022 Sep; 36(7):1208-1212. PubMed ID: 35428402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-Level Variations in the Utilization of Lung Cancer Screening Among Medicare Fee-for-Service Beneficiaries: An Analysis of the 2015 to 2017 Physician and Other Supplier Data.
    Liu B; Dharmarajan K; Henschke CI; Taioli E
    Chest; 2020 Apr; 157(4):1012-1020. PubMed ID: 31759960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer screening eligibility and use with low-dose computed tomography: Results from the 2018 Behavioral Risk Factor Surveillance System cross-sectional survey.
    Narayan AK; Gupta Y; Little BP; Shepard JO; Flores EJ
    Cancer; 2021 Mar; 127(5):748-756. PubMed ID: 33206388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Goes into Patient Selection for Lung Cancer Screening? Factors Associated with Clinician Judgments of Suitability for Screening.
    Núñez ER; Zhang S; Glickman ME; Qian SX; Boudreau JH; Lindenauer PK; Slatore CG; Miller DR; Caverly TJ; Wiener RS
    Am J Respir Crit Care Med; 2024 Jan; 209(2):197-205. PubMed ID: 37819144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.